TTP vs Zühlke: full comparison for 2026
Quick verdict
TTP (4.4/5) edges ahead of Zühlke (4.4/5) overall. TTP is the better choice for pharma device programs, inhalers and injectors. Zühlke is the stronger option for european medtech firms modernizing device software. The right choice depends on your project size, budget, and required tech stack.
TTP vs Zühlke: head-to-head summary
| Criterion | TTP | Zühlke |
|---|---|---|
| Founded | 1987 | 1968 |
| HQ | Melbourn, Cambridgeshire, UK | Schlieren, Switzerland |
| Team size | Not published | 1,500–2,000 |
| Rating | 4.4 / 5 | 4.4 / 5 |
| Primary differentiator | Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients | A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program |
| Pricing model | Time and materials, phased fixed project | Time and materials, fixed project |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Ultrasound, Microfluidics, Embedded C/C++ | Embedded C/C++, Embedded Linux, Cloud (AWS/Azure) |
| Industries served | Drug delivery, Surgical & robotics, Diagnostics & lab devices | Digital health, Diagnostics & lab devices, Surgical & therapeutic devices, Financial services |
TTP vs Zühlke: overview
TTP
TTP (The Technology Partnership) has operated for around 40 years from its own science park in Melbourn, South Cambridgeshire. In December 2021 TTP Group moved to 100% employee ownership through an Employee Ownership Trust. Its Medical Devices team works on drug delivery, surgical systems and diagnostics, and the wider company does deep technology work in sectors such as life science instruments and industrial products. Headcount is not published in a form we could verify.
Zühlke
Partner-owned since its 1968 founding in Switzerland, Zühlke is headquartered in Schlieren near Zurich, with teams in Germany, Austria, the UK, Serbia and Asia. Its headcount is somewhere between 1,500 and 2,000 depending on the source. In healthcare it covers regulated device and systems engineering, connected-device software and the cloud and analytics platforms around devices, and it states more than 50 years of medtech experience (per company website; independently unverifiable).
Services and capabilities: TTP vs Zühlke
| Capability | TTP | Zühlke |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✓ |
| SaMD & companion apps | ✗ | ✓ |
| Connected devices & IoT | ✗ | ✓ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✓ | ✗ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✗ | ✗ |
Tech stack comparison: TTP vs Zühlke
| Framework / platform | TTP | Zühlke |
|---|---|---|
| Embedded C/C++ | ✓ | ✓ |
| Embedded Linux | N/A | ✓ |
| RTOS | N/A | N/A |
| BLE | N/A | N/A |
| Cloud (AWS/Azure) | N/A | ✓ |
| IEC 62304 | N/A | ✓ |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | ✓ | N/A |
| Qt | N/A | ✓ |
Pricing comparison: TTP vs Zühlke
| Criterion | TTP | Zühlke |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Consulting, Fixed project, Time & materials | Consulting, Dedicated team, Fixed project, Time & materials |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: TTP vs Zühlke
| Dimension | TTP | Zühlke |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Drug delivery, Surgical & robotics, Diagnostics & lab devices | Digital health, Diagnostics & lab devices, Surgical & therapeutic devices |
| Best use cases | Designing an autoinjector or inhaler for a pharma combination product, Developing a surgical energy device | Rebuilding the embedded and cloud software of an established diagnostics platform, EU MDR remediation of legacy device software |
| Typical project type | Consulting | Consulting |
TTP vs Zühlke: pros and cons
| TTP | |
|---|---|
| + | Employee ownership since 2021 removes pressure from outside investors |
| + | Well regarded for drug delivery devices, an area where mechanics and human factors decide success |
| + | Own science park with lab and workshop space for physical prototyping |
| + | Specialist depth in ultrasound and fluidics |
| - | Does not publish headcount or rates, which makes early budgeting harder |
| - | UK-centric delivery; US clients work across time zones |
| - | Pricing sits with the premium Cambridge consultancies |
| Zühlke | |
|---|---|
| + | Partner ownership keeps the firm independent of a large holding group |
| + | Large enough to staff hardware, embedded, cloud and data roles at the same time |
| + | Delivery centres in Serbia and Asia give some cost flexibility compared with all-Swiss teams |
| + | Experience with EU MDR environments in German-speaking markets |
| - | Much of the firm works outside healthcare, so check that the proposed team is from the medtech practice |
| - | Swiss and German rates are high for the onshore part of a team |
| - | Industrial design and manufacturing are not core offerings |
Who should choose TTP?
A typical fit: designing an autoinjector or inhaler for a pharma combination product.
Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Surgical & robotics, Diagnostics & lab devices.
Who should choose Zühlke?
A typical fit: rebuilding the embedded and cloud software of an established diagnostics platform.
A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program. Minimum engagement is not publicly disclosed. Works best with clients in Digital health, Diagnostics & lab devices, Surgical & therapeutic devices, Financial services.
Decision matrix: TTP vs Zühlke
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | TTP |
| You need a large dedicated team for an ongoing programme | Zühlke |
| Your budget is at the lower end | Compare: TTP (Not disclosed) vs Zühlke (Not disclosed) |
| You need specialist depth in a specific vertical | Zühlke |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: TTP vs Zühlke
| Use case | TTP fit | Zühlke fit | Winner |
|---|---|---|---|
| Designing an autoinjector or inhaler for a pharma combination product | Strong | Strong | Both equally |
| Developing a surgical energy device | Strong | Limited | TTP |
| Rebuilding the embedded and cloud software of an established diagnostics platform | Limited | Strong | Zühlke |
| EU MDR remediation of legacy device software | Limited | Strong | Zühlke |
Verdict: TTP vs Zühlke
TTP (4.4/5) is the stronger overall choice for most Medical Device Development projects. Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients.
Zühlke (4.4/5) is worth a look if you need EU MDR remediation of legacy device software. If your situation matches that, Zühlke is a competitive option.
Related comparisons
TTP vs Zühlke FAQ
Is TTP better than Zühlke?
TTP (4.4/5) scores higher overall, but "better" depends on your use case. TTP's strongest advantage: employee ownership since 2021 removes pressure from outside investors. Zühlke's strongest advantage: partner ownership keeps the firm independent of a large holding group.
How do TTP and Zühlke differ in pricing?
TTP uses time and materials, phased fixed project pricing. Zühlke uses time and materials, fixed project pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: TTP or Zühlke?
Zühlke is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between TTP and Zühlke?
TTP's primary differentiator is: employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients. Zühlke's primary differentiator is: a device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program. They also differ in team size (Not published vs 1,500–2,000), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Drug delivery, Surgical & robotics vs Digital health, Diagnostics & lab devices).
Verify all details directly with each company before making a decision.